Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value:
$1.49B
Total Bought:
$292.75M
Total Sold:
$739.56M
Net Transaction:
-$446.81M
Notable People:
Bihua Chen, Cormorant Asset Management Gp,
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Parabilis Medicines Inc4,615,6124,615,6120$126.33M$149.04M10.01%+$22.71M
Praxis Precision Medicines, Inc.(PRAX)640,000500,000-140,000$214.27M$145.62M9.78%-$68.65M
Rapport Therapeutics, Inc.(RAPP)2,657,5212,457,521-200,000$110.74M$82.57M5.54%-$28.17M
Edgewise Therapeutics, Inc.(EWTX)2,510,0001,860,000-650,000$101.98M$75.52M5.07%-$26.47M
Bridgebio Oncology Therapeut17,878,59417,878,5940$136.23M$73.30M4.92%-$62.93M
Erasca, Inc.(ERAS)6,000,0005,000,000-1,000,000$109.92M$73.30M4.92%-$36.62M
Blossomhill Therapeutics Inc03,614,034+3,614,034$0$67.37M4.52%+$67.37M
Adlai Nortye Group LtdADS3,978,2293,978,2290$45.75M$63.65M4.27%+$17.90M
Dianthus Therapeutics, Inc.(DNTH)750,000500,000-250,000$73.11M$44.02M2.96%-$29.09M
ABIVAX Société AnonymeADS(ABVX)675,000425,000-250,000$89.95M$42.08M2.83%-$47.87M
Bright Minds Biosciences Inc900,000800,000-100,000$63.18M$39.86M2.68%-$23.32M
Electra Therapeutics Inc03,365,533+3,365,533$0$37.86M2.54%+$37.86M
MoonLake ImmunotherapeuticsCL A(MLTX)3,205,4332,855,433-350,000$62.41M$33.41M2.24%-$29.00M
Oruka Therapeutics, Inc.(ORKA)533,340400,000-133,340$50.76M$33.32M2.24%-$17.44M
Attovia Therapeutics Inc01,788,815+1,788,815$0$30.66M2.06%+$30.66M
Faeth Therapeutics Inc1,028,2421,028,2420$7.66M$30.58M2.05%+$22.92M
Latigo Biotherapeutics Inc01,815,740+1,815,740$0$30.32M2.04%+$30.32M
Agomab Therapeutics NvADS2,465,3482,465,3480$32.00M$27.37M1.84%-$4.63M
Opus Genetics Inc05,500,000+5,500,000$0$26.62M1.79%+$26.62M
Climb Bio Inc2,106,0002,106,0000$27.46M$24.16M1.62%-$3.31M
Freenome Inc01,431,032+1,431,032$0$22.54M1.51%+$22.54M
MBX Biosciences, Inc.(MBX)550,000375,000-175,000$30.36M$21.98M1.48%-$8.38M
Biohaven Ltd.(BHVN)2,610,0001,510,000-1,100,000$38.84M$20.16M1.35%-$18.68M
Adarx Pharmaceuticals Inc0962,898+962,898$0$19.20M1.29%+$19.20M
Eyepoint Inc7,000,0005,750,000-1,250,000$100.10M$18.80M1.26%-$81.30M
Tango Therapeutics, Inc.(TNGX)1,300,000700,000-600,000$40.64M$17.46M1.17%-$23.17M
Damora Therapeutics Inc0800,000+800,000$0$17.02M1.14%+$17.02M
BridgeBio Pharma, Inc.(BBIO)550,000250,000-300,000$40.96M$16.45M1.10%-$24.51M
Cue Biopharma Inc0625,285+625,285$0$16.18M1.09%+$16.18M
Corbus Pharmaceuticals Hldgs2,344,9712,344,9710$22.00M$15.99M1.07%-$6.00M
Bioage Labs Inc2,390,6052,240,605-150,000$58.59M$15.89M1.07%-$42.71M
Alumis Inc3,285,5962,075,000-1,210,596$92.46M$15.33M1.03%-$77.12M
Olema Pharmaceuticals Inc2,150,0001,750,000-400,000$26.90M$15.12M1.02%-$11.78M
Pharvaris N V
COM
750,000450,000-300,000$25.93M$14.27M0.96%-$11.66M
Helix Acquisition Corp IiiCL A1,297,5001,297,5000$13.81M$13.78M0.93%-$25.9K
Spyre Therapeutics, Inc.(SYRE)225,000125,000-100,000$19.98M$11.13M0.75%-$8.85M
Definium Therapeutics, Inc.(DFTX)400,000275,000-125,000$18.82M$10.47M0.70%-$8.35M
Aclaris Therapeutics Inc01,750,000+1,750,000$0$9.21M0.62%+$9.21M
Amylyx Pharmaceuticals, Inc.(AMLX)200,000300,000+100,000$3.59M$8.73M0.59%+$5.14M
Cabaletta Bio Inc5,000,0004,500,000-500,000$15.55M$8.64M0.58%-$6.91M
Inhibrx Biosciences, Inc.(INBX)050,000+50,000$0$5.00M0.34%+$5.00M
Kailera Therapeutics Inc550,000400,000-150,000$12.12M$4.57M0.31%-$7.55M
Jade Biosciences Inc0300,000+300,000$0$4.21M0.28%+$4.21M
Ibio Inc3,570,0003,570,0000$6.25M$4.21M0.28%-$2.03M
Tarsus Pharmaceuticals, Inc.(TARS)100,00050,000-50,000$6.29M$3.93M0.26%-$2.36M
Roivant Sciences Ltd.SHS(ROIV)475,000100,000-375,000$16.81M$3.66M0.25%-$13.15M
Enliven Therapeutics Inc150,00075,000-75,000$7.61M$3.44M0.23%-$4.17M
Ascendis Pharma A/S(ASND)50,00015,000-35,000$13.34M$3.42M0.23%-$9.92M
Odyssey Therapeutics Inc175,000125,000-50,000$3.27M$2.78M0.19%-$496.8K
Newamsterdam Pharma Company
ORDINARY SHARES
500,000100,000-400,000$16.95M$2.43M0.16%-$14.51M
Boundless Bio Inc1,000,000940,000-60,000$2.50M$2.36M0.16%-$140.6K
Insmed Incorporated(INSM)75,00020,000-55,000$8.00M$2.28M0.15%-$5.71M
Braveheart Bio Inc070,000+70,000$0$1.41M0.09%+$1.41M
Research Alliance Corp IiiCL A370,000125,000-245,000$3.96M$1.35M0.09%-$2.61M
Arcutis Biotherapeutics, Inc.(ARQT)175,00050,000-125,000$4.59M$1.32M0.09%-$3.27M
Arrowhead Pharmaceuticals, Inc.(ARWR)50,00015,000-35,000$4.08M$981.8K0.07%-$3.09M
Cogent Biosciences, Inc.(COGT)100,00030,000-70,000$3.87M$960.6K0.06%-$2.91M
Structure Therapeutics IncADS75,00030,000-45,000$4.03M$938.1K0.06%-$3.09M
Vaxcyte, Inc.(PCVX)50,00015,000-35,000$2.91M$853.5K0.06%-$2.05M
Quince Therapeutics Inc5,4985,4980$100.0K$170.5K0.01%+$70.5K
Altimmune, Inc.(ALT)1,250,0000-1,250,000$3.80M$0—-$3.80M
Crinetics Pharmaceuticals In125,0000-125,000$4.68M$0—-$4.68M
Damora Therapeutics, Inc.(DMRA)1,000,0000-1,000,000$26.01M$0—-$26.01M
Page 1 of 1
Cormorant Asset Management, LP — 13F Holdings — Q3 2026 | TickerTrail